What is the potential of daratumumab in combination therapy for myeloma?
Ibrutinib combined with TGR-1202 in CLL and mantle cell lymphoma (MCL): preliminary results
Current standard of care for patients who are eligible for autologous stem cell transplantation
ASH 2017 President’s meeting highlights
The regulation of biosimilars